Expert Committee discuss strategy for availability and delivery mechanism of COVID-19 vaccines

Experts also deliberated on creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine including tracking of vaccination process with particular focus on last-mile delivery
Read Article

National Expert Group on Vaccine Administration for COVID-19, met for the first time on August 12. The meeting was chaired by Dr V K Paul, Member, Niti Aayog along with Secretary (Ministry of Health and Family Welfare) as co-Chair.

The expert group deliberated on conceptualisation and implementation mechanisms for the creation of a digital infrastructure for inventory management and delivery mechanism of the vaccine including tracking of vaccination process with particular focus on last-mile delivery. They discussed on broad parameters guiding the selection of COVID-19 vaccine candidates for the country and sought inputs from Standing Technical Sub-Committee of National Technical Advisory Group on Immunization (NTAGI). The group delved on the procurement mechanisms for COVID-19 vaccine, including both indigenous and international manufacturing along with guiding principles for prioritisation of population groups for vaccination.

The expert group discussed on the financial resources required for procurement of COVID-19 vaccine and various options of financing the same. Available options in terms of delivery platforms, cold chain and associated infrastructure for the rollout of COVID-19 vaccination were also taken up. Further, strategy and follow-up action on all possible scenarios to ensure equitable and transparent delivery of vaccine was deliberated upon. Issues related to vaccine safety and surveillance were taken up and strategy for community involvement through transparent information and awareness creation were discussed.

India’s support to its key neighbours and development partner countries for COVID-19 vaccines was deliberated upon. The expert group discussed that India will leverage domestic vaccine manufacturing capacity and will also engage with all international players for early delivery of vaccines not only in India but also in low and middle-income countries.

The Committee also advised all the States not to chart separate pathways of procurement.

Covid 19 vaccineDr V K PaulMinistry of Health and Family WelfareNiti Aayogvaccine deliveryvaccine production
Comments (0)
Add Comment